regadenoson has been researched along with theophylline in 4 studies
Studies (regadenoson) | Trials (regadenoson) | Recent Studies (post-2010) (regadenoson) | Studies (theophylline) | Trials (theophylline) | Recent Studies (post-2010) (theophylline) |
---|---|---|---|---|---|
321 | 53 | 264 | 20,076 | 1,612 | 1,383 |
Protein | Taxonomy | regadenoson (IC50) | theophylline (IC50) |
---|---|---|---|
Adenosine receptor A1 | Bos taurus (cattle) | 2.43 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
de Lera Ruiz, M; Lim, YH; Zheng, J | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Demkow, M; Kępka, C; Kruk, M; Marczak, M; Miłosz-Wieczorek, B; Oleksiak, A; Śpiewak, M | 1 |
Page, RL; Pham, VA; Quaife, RA; Raines, J; Shakowski, C | 1 |
2 review(s) available for regadenoson and theophylline
Article | Year |
---|---|
Adenosine A2A receptor as a drug discovery target.
Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction | 2014 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for regadenoson and theophylline
Article | Year |
---|---|
Safety of regadenoson with theophylline reversal during dynamic computed tomography perfusion and magnetic resonance imaging in patients with coronary artery disease.
Topics: Coronary Artery Disease; Female; Humans; Magnetic Resonance Imaging; Myocardial Perfusion Imaging; Perfusion; Prospective Studies; Purines; Pyrazoles; Theophylline; Tomography, Emission-Computed, Single-Photon | 2020 |
Safety and efficacy of IV theophylline for regadenoson-associated side effect reversal.
Topics: Aminophylline; Drug-Related Side Effects and Adverse Reactions; Humans; Purines; Pyrazoles; Theophylline | 2023 |